Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The latest news, stories and exciting findings from across the Oxford cancer research community

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Oxford Cancer Analytics awarded £1.27M to revolutonise lung cancer management

OXcan, an Oxford University spin out, has raised money to apply their machine learning approach to lung cancer early detection

Vaccine for treating cancer made possible using Oxford COVID vaccine technology

A new publication from Benoit Van den Eynde's group has shown that a viral vector cancer vaccine generates effective anti-tumour immune responses and, in combination with immunotherapy, decreases tumour size and increases survival rates in mouse models.

Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection

Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.

World Chronic Lymphoid Leukaemia Day 2021

Researchers from Oxford University and OUH are joining celebrations for the first world CLL day on 1 September 2021.

Two Oxford immunotherapy research projects awarded funding by Prostate Cancer UK

Prostate Cancer UK have invested £1.7 million into five immunotherapy projects, including two from Profs Kate Vallis, Richard Bryant and Eileen Parkes at the University of Oxford. Read about their funded work.

Oxford spin out partners with J&J to transform lung cancer treatment

Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.

NCITA Publishes Comment Article in the British Journal of Cancer

Read their introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers.

First patient dosed with drug designed to re-sensitise patients to cancer treatment

The first patient has been dosed using new drug PORT-2 in Oxford, which hopes to improve treatment options for melanoma and Non-Small Cell Lung Cancer (NSCLC) and resensitise patients with checkpoint therapy-resistant tumours

Mechanism behind repair of cancer-inducing mutations discovered

New research from Ross Chapman’s lab has discovered the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

Oxford Cancer – behind the brand

Our new brand represents how Oxford researchers are working across disciplines to translate their discoveries into better care for cancer patients. Meet the new brand and the people behind it.

AI software to help clinicians diagnose lung cancer earlier and reduce patient waiting lists

A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding.

Protein structure solution paves way for improved anti-cancer drugs

A new study from the Newstead group at the Department of Biochemistry has solved the structure of the human folate transporter, paving the way for improved anticancer drugs.

New network Oxford Cancer launches

A new pan-divisional initiative has launched at the University of Oxford. Bringing together the collective force of cancer research, outreach and care that happen across the city of Oxford.

The next step in personalised cancer medicine

Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.

Oxford Cancer welcomes Professor Stefan Constantinescu

Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.

Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens

University of Oxford researchers have begun recruitment to a study looking at whether chemotherapy medication can reach pancreatic tumours more effectively if encapsulated within a heat-sensitive shell and triggered with focused ultrasound.

14 new CRUK Oxford Centre Development Fund Awardees

The awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.

Oxford wins government funding to evaluate prostate cancer detection system

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.

Two clinical academic research partnerships awarded to Oxford researchers

Congratulations to Dr Karthik Ramasamy & Dr John Jacob on their CARP awards from the Medical Research Council. Find more about their work that is being funded.

Load More